Swiss National Bank Raises Stock Holdings in Anterix Inc. $ATEX

Swiss National Bank lifted its holdings in Anterix Inc. (NASDAQ:ATEXFree Report) by 8.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,850 shares of the company’s stock after purchasing an additional 1,600 shares during the period. Swiss National Bank owned about 0.11% of Anterix worth $727,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of Anterix by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 1,050,022 shares of the company’s stock valued at $38,431,000 after purchasing an additional 15,043 shares in the last quarter. Garnet Equity Capital Holdings Inc. increased its stake in shares of Anterix by 33.3% in the 4th quarter. Garnet Equity Capital Holdings Inc. now owns 388,829 shares of the company’s stock valued at $11,925,000 after purchasing an additional 97,127 shares in the last quarter. Nuveen Asset Management LLC increased its stake in shares of Anterix by 26.4% in the 4th quarter. Nuveen Asset Management LLC now owns 185,573 shares of the company’s stock valued at $5,692,000 after purchasing an additional 38,770 shares in the last quarter. Northern Trust Corp increased its stake in shares of Anterix by 8.5% in the 4th quarter. Northern Trust Corp now owns 133,270 shares of the company’s stock valued at $4,087,000 after purchasing an additional 10,463 shares in the last quarter. Finally, Kirr Marbach & Co. LLC IN increased its stake in shares of Anterix by 4.7% in the 1st quarter. Kirr Marbach & Co. LLC IN now owns 96,797 shares of the company’s stock valued at $3,543,000 after purchasing an additional 4,386 shares in the last quarter. Hedge funds and other institutional investors own 87.67% of the company’s stock.

Analysts Set New Price Targets

Separately, Wall Street Zen lowered Anterix from a “hold” rating to a “sell” rating in a research note on Saturday, August 16th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Strong Buy” and an average price target of $67.00.

View Our Latest Stock Report on Anterix

Anterix Trading Up 1.7%

ATEX stock opened at $22.76 on Wednesday. Anterix Inc. has a 12-month low of $20.61 and a 12-month high of $42.91. The stock has a market cap of $426.52 million, a price-to-earnings ratio of 14.59 and a beta of 0.89. The business’s 50-day moving average is $23.46 and its 200 day moving average is $29.67.

Anterix (NASDAQ:ATEXGet Free Report) last issued its earnings results on Tuesday, August 12th. The company reported ($0.48) earnings per share for the quarter, topping the consensus estimate of ($0.54) by $0.06. The business had revenue of $1.42 million for the quarter, compared to analysts’ expectations of $1.51 million. Anterix had a negative return on equity of 23.87% and a net margin of 495.14%. As a group, equities analysts forecast that Anterix Inc. will post -1.53 EPS for the current fiscal year.

Anterix Company Profile

(Free Report)

Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.

Featured Stories

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.